XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
X Partners With Gemini, Kraken & Moomoo for Timeline Trading
X has announced partnerships with Gemini, Kraken, and Moomoo to let users trade directly from the social media timeline, bringing brokerage and crypto exchange...
Bitcoin Hits $87,000 as Crypto Liquidations Top $1 Billion
Bitcoin briefly tapped $87,000 in a sharp upward move that triggered roughly $1 billion in crypto liquidations across derivatives markets, wiping out leveraged...
Stolen NuNet Key Minted 408.5M NTX in Fetch.ai Theft
A compromised NuNet private key was used to mint 408. 5 million NTX tokens, with the receiving wallet identified as the same address linked to a separate $1.
Bitcoin Nears $86,000, Erasing $86B U.S. Spot ETF Paper Loss
Bitcoin climbed to $85,851 on September 21, 2026, up 5. 57% in 24 hours, pushing the price within striking distance of $86,000, a threshold that, according to u...
Balancer Recovers 296.4 ETH from V1 Exploit; LP Plan Unclear
Balancer has recovered 296. 4 ETH linked to an exploit of its V1 protocol, but the path to compensating affected liquidity providers remains undefined, with no...
Bitcoin Breaks $85,000 as $648M in Crypto Shorts Liquidated
Bitcoin pushed above $85,000 on April 22, 2025, triggering a wave of forced short closures that wiped out more than $648 million in crypto short positions withi...
